BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35042378)

  • 1. Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
    Liang R; Zheng L; Ji T; Zheng J; Liu J; Yuan C; Huang Q; Yang M
    Lupus; 2022 Feb; 31(2):187-193. PubMed ID: 35042378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
    Huang Q; Shen S; Qu H; Huang Y; Wu D; Jiang H; Yuan C
    Ann Transl Med; 2020 Jan; 8(1):9. PubMed ID: 32055600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
    Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.
    Shi LH; Liu ZY; Yu SJ; Xia Q; Zhao J; Wu R
    Int J Rheum Dis; 2023 Aug; 26(8):1464-1473. PubMed ID: 37366596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished white matter integrity in patients with systemic lupus erythematosus.
    Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
    Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR Diffusion Tractography to Identify and Characterize Microstructural White Matter Tract Changes in Systemic Lupus Erythematosus Patients.
    Shastri R; Shah G; Wang P; Cagnoli P; Schmidt-Wilcke T; McCune J; Harris R; Sundgren P
    Acad Radiol; 2016 Nov; 23(11):1431-1440. PubMed ID: 27746120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
    Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
    Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted resting-state interhemispheric functional connectivity in systemic lupus erythematosus patients with and without neuropsychiatric lupus.
    Wang YL; Jiang ML; Huang LX; Meng X; Li S; Pang XQ; Zeng ZS
    Neuroradiology; 2022 Jan; 64(1):129-140. PubMed ID: 34379142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
    George-Chandy A; Trysberg E; Eriksson K
    Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus.
    Yang J; Li C; Chi S; Wei H; Du W; Hu Q
    Immun Inflamm Dis; 2022 Nov; 10(11):e719. PubMed ID: 36301034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus.
    Guo Y; Li X; Li R; Li Y; Wang Z; Liu H; Cao S; Li R; Zhao Y; Wang Q; Sun X
    Clin Exp Rheumatol; 2022 Nov; 40(11):2078-2087. PubMed ID: 35084329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.
    Yang Y; Yuan C; Shen SQ; Wang XE; Mei QH; Jiang WQ; Huang Q
    Mediators Inflamm; 2017; 2017():5047898. PubMed ID: 28154472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.